The classes
Class I, II, III — and the 2026 picture: 51 Class I recalls at 53.4M units, cardiovascular devices leading with 177 events.
Free field guide · PDF
FDA Medical Device Recall2026 Field Guide
The classes, the 806 report, and the enhancement line — with the recall practice you need.
- Class I units
- 53.4M
- Device share
- 47.3%
- 806 window
- 10 wdays
Sourced from FDA and verified 2026 publications.
Download the free guide
Enter your work email and we'll send the PDF straight to your inbox.
What's inside
Five pages, zero fluff
Every figure in this guide traces to a named source — FDA and verified 2026 publications.
The 806 report
21 CFR 806.10 — who reports, the 10-working-day window, the 13 content items, and what's exempt (with records still required).
The enhancement line
The final guidance line: enhancements that improve a non-violative device need no report — spec failures are recalls.
Sources & scope
- 24x7mag.com, Medical Device Recall Events Drop 5% as Affected Units Surge 517%.
- worldhealth.net, Cardiovascular and Vascular Devices Lead 2026 Recalls.
- fda.gov, Recalls, Corrections and Removals (Devices).
- lexology.com, Final FDA guidance clarifies distinction between medical device recalls and enhancements.
This guide is market-access intelligence, not regulatory or legal advice. Recall classifications, reporting obligations, and guidance interpretations change — professional review is required before business use.
Market Access Strategy Session
Recall exposure on your 2026 roadmap? Start with the full picture.
A Market Access Strategy Session maps your recall readiness — classification practice, 806 reporting, and vigilance planning.
Professional review is required before business use.
Back to ghmap.io Questions? Talk to our team